Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer. C. J. Whatcott, S. Ng, M. T. Barrett, G. Hostetter, D. D. Von Hoff, H. Han. PLoS One, 2017; In Press
Preparation and metabolic assay of 3-dimensional spheroid co-cultures of pancreatic cancer cells and fibroblasts. P. Noel, R. Muñoz, G. W. Rogers, A. Neilson, D. D. Von Hoff, H. Han. J Vis Exp. 2017; Epub May.2017
Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression. K. Yoshida, S. Toden, P. Ravindranathan, H. Han, A. Goel. Carcinogenesis. Epub June, 2017.
Clinical study of genomic drivers in pancreatic ductal adenocarcinoma. M. T. Barrett, R. Deiotte, E. Lenkiewicz, S. Malasi, T. Holley, L. Evers, R. G. Posner, T. Jones, H. Han, M. Sausen, V. E. Velculescu, J. Drebin, P. O’Dwyer, G. Jameson, R. K. Ramanathan, D. D. Von Hoff. Br J Cancer. 2017; 117:572-582.
Blocking nerve growth factor signaling inhibits perineural invasion in pancreatic cancer. A. Bapat, R. M. M. Munoz, D. D. Von Hoff, and H. Han. PLoS One, 2016;11:e0165586.
Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer. C. J. Whatcott, C. H. Diep, P. Jiang, A. Watanabe, J. LoBello, C. Sima, G Hostetter, H. M. Shepard, D. D. Von Hoff, H. Han. Clin Cancer Res. 2015; 21:3561-8.
Orchestrating the tumor microenvironment to improve survival for patients with pancreatic cancer: normalization, not destruction. C. J. Whatcott, H. Han, D. D. Von Hoff. Cancer J. 2015; 21:299-306